{
  "id": "mhgap#screening_cues_43cea7cd",
  "content": "preferences and careful consideration of the balance of benefits and\nharms. Antidepressant medicine alone for adults with moderate-to-severe\ndepression should only be considered when psychological interventions are\nnot available. Providers should keep in mind the possible adverse effects\nassociated with antidepressant medicines, and individual preferences.\nStrength of recommendation: Conditional\nCertainty of evidence: Low\nJustification y In terms of treatment efficacy, combined\ny Evidence was extracted from two meta-analyses: psychological interventions and antidepressants\nCuijpers et al., 2020 (101 studies) (140); and showed the best results across most of the analyses.\nFurukawa et al., 2021 (81 RCTs) (141). – Combined treatment was better than\ny Antidepressant medicines are as effective as pharmacotherapy alone in the reduction of\npsychological interventions in the short term in the depressive symptoms (SMD = 0.33), treatment\ntreatment of depression. However, psychological response (RR = 1.25) and remission (RR = 1.23).\ninterventions showed higher sustained response These effects were sustained at 6–12 months\nthan antidepressants over the long term and follow-up (RR = 0.72), favouring combined\nantidepressants have more adverse effects. treatment.\n62\n3. Recommendations\n– Combined treatment was better than Remarks\npsychotherapy alone in the reduction of y The term “combined treatment” refers to",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "screening_cues",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues preferences and careful consideration of the balance of benefits and\nharms. Antidepressant medicine alone for adults with moderate-to-severe\ndepression should only be considered when psychological interventions are\nnot available. Providers should keep in mind the possible adverse effects\nassociated with antidepressant medicines, and individual preferences.\nStrength of recommendation: Conditional\nCertainty of evidence: Low\nJustification y In terms of treatment efficacy, combined\ny Evidence was extracted from two meta-analyses: psychological interventions and antidepressants\nCuijpers et al., 2020 (101 studies) (140); and showed the best results across most of the analyses.\nFurukawa et al., 2021 (81 RCTs) (141). – Combined treatment was better than\ny Antidepressant medicines are as effective as pharmacotherapy alone in the reduction of\npsychological interventions in the short term in the depressive symptoms (SMD = 0.33), treatment\ntreatment of depression. However, psychological response (RR = 1.25) and remission (RR = 1.23).\ninterventions showed higher sustained response These effects were sustained at 6–12 months\nthan antidepressants over the long term and follow-up (RR = 0.72), favouring combined\nantidepressants have more adverse effects. treatment.\n62\n3. Recommendations\n– Combined treatment was better than Remarks\npsychotherapy alone in the reduction of y The term “combined treatment” refers to Preferences and careful consideration of the balance of benefits and\nharms. antidepressant medicine alone for adults with moderate-to-severe\ntrầm cảm should only be considered when psychological interventions are\nnot ava..."
}